What is Adamax?
Adamax is based on the Semax sequence (ACTH(4–7)-Pro-Gly-Pro) with an additional modification intended to increase stability. A peer-reviewed structural description has not been published yet.
More data in the lexicon entry on Adamax.
More data in the lexicon entry on Semax.
State of research
Adamax belongs to a newer generation of semax derivatives that appear mainly in the research peptide trade. No published structure description or dedicated studies exist so far; information on structure and stability comes from manufacturers.
Work with Adamax therefore relies on semax research questions: BDNF expression, melanocortin pathways and models of neuronal injury. Because the evidence is thin, identity testing matters especially; the current batch report is in the lab report archive.
Status and quality
Adamax is not approved as a medicine; the evidence is limited to preclinical and manufacturer information. Peptidkauf sells Adamax solely as a research reagent for laboratory and in-vitro use and gives no dosing or application advice.
An independent laboratory tests every batch for purity (HPLC), identity and measured content before it goes on sale; the reports and their verification keys are in the lab report archive. The material ships as lyophilised powder in a glass vial; storage and laboratory handling are covered under storage & handling.
Related products and articles
The parent peptide: semax and N-acetyl semax. Comparison: semax vs. selank. More in the cognition research area.
